Skip to main content
Isomer
  1. Home
  2. Automated
  3. List of product information
  4. FEDAC COMPOUND LINCTUS [SIN03195P]

FEDAC COMPOUND LINCTUS [SIN03195P]

Active ingredients: FEDAC COMPOUND LINCTUS

Last updated 26 October 2025

Product Info

FEDAC COMPOUND LINCTUS

[SIN03195P]

Product information

Active Ingredient and Strength

CODEINE PHOSPHATE - 10 MG/5 ML
PSEUDOEPHEDRINE HCL - 30 MG/5 ML
TRIPROLIDINE HCL - 1.25 MG/5 ML

Dosage Form

ELIXIR

Manufacturer and Country

ICM PHARMA PTE. LTD. - SINGAPORE

Registration Number

SIN03195P

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Forensic Classification

PHARMACY ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

R05DA20

INDICATIONS:
Temporary relief of coughs and upper respiratory symptoms including nasal congestion associated with allergy or the common cold.

RECOMMENDED DOSAGE:
Adults and children over 12 years: 2 teaspoonfuls 3 times a day
Children and Adolescents: Codeine should not be used in children below 12 years old.
In those 12 years old and above, codeine may be used for the treatment of unproductive cough which is not relieved by other anti-tussives alone. The lowest effective dose should be used for the shortest possible duration.

CONTRA-INDICATIONS:
In patients intolerant to Pseudoephedrine HCI or Triprolidine HCI or Codeine Phosphate. Patients with severe hypertension, severe coronary artery disease and in patients on MAO inhibitors. FEDAC COMPOUND LINCTUS should not be used in newborn or premature infants and should not be used to treat lower respiratory tract symptoms including asthma.